Advanced search
Publication Cover
Hematology Volume 12, 2007 - Issue 3
Submit an article Journal homepage
229
Views
25
CrossRef citations to date
0
Altmetric
Current Clinical Practice

Haemopoietic stem cell transplantation—an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology

Sabrina KapoorDepartment of HaematologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
,
A Gerry WilsonDepartment of RheumatologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Division of Genomic Medicine, University of Sheffield, Sheffield, UK
,
Basil SharrackDepartment of NeurologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
,
Alan LoboDepartment of GastroenterologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
,
Mohammed AkilDepartment of RheumatologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
,
Lingyun SunDepartment of RheumatologyDrum Tower Hospital, Nanjing, P.R. China
,
Chris D DalleyDepartment of HaematologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
&
John A SnowdenDepartment of HaematologySheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
 show all
Pages 179-191 | Published online: 04 Sep 2013

  • Snowden JA, Brooks PM, Biggs JC. Haemopoietic stem cell transplantation for autoimmune disease (review). Br J Haematol 1997;99:9–22.
  • Hough RE, Snowden JA, Wulffraat N. Haemopoietic stem cell transplantation in autoimmune diseases: A European perspec-tive (review). Br J Haematol 2005;128:432–459.
  • Tyndall A, Gratwohl A. Blood and marrow stem cell transplantation in autoimmune disease: A consensus report written on behalf of the European League Against Rheuma-tism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997;36:390–392.
  • Moore IT, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemato-poietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002;46:2301–2309.
  • Burt RK, Fassas A, Snowden JA, et al. Collection of hematopoietic stem cell from patients with autoimmune disease. Bone Marrow Transplant 2001;28:1–12.
  • Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kötter I, Kozak T, Lisukov I, Lowenberg R, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW. Tyndall A, for the Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005;35:869–879.
  • Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, Fassas A, Snowden J, Schuening F, Myint H, Patel DP, Collier D, Heslop H, Krance R, Statkute L, Verda L, Traynor A, Kozak T, Hintzen RQ, Rose JW, Voltarelli J, Cohen BA, Craig RM, Varg J, Barr WG. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens (review). Arthritis Rheum, 2006;54:3750–3760.
  • Zandman-Goddard G, Tweezer-Zaks N, Shoenfield Y. New therapeutic strategies for systemic sclerosis�a critical analysis of the literature. Clin Dev Immunol 2005;12:165–173.
  • Farge D, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EU-LAR Registry. Ann Rheum Dis 2004;63:974–981.
  • Furst DE, et al. High dose immunotherapy with stem cell rescue in severe systemic scierosis: An idea that is moving forward. J Rheumatol 2004;31:2331–2335.
  • Al-Mashaleh M, et al. Resolution of sclerodermatous myocarditis after autologous stem cell transplantation. Ann Rheum Dis 2006;65:1247–1248.
  • Nash RA, et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosis. Arthritis Rheum 2006;54:1982–1986.
  • Khorshid O, et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004;31:2513.
  • Ginzler EM, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219–2228.
  • Leandro NJ, Edwards JC, Cambridge G. An open study of B lymphocyte depletion in SLE. Arthritis Rheum 2002; 46:2673–2677.
  • Burt RK, et al. Nonmyeloblative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006;295:559–560.
  • Jayne D, et al. Autologous stem cell transplantation for systemic lupus erythematous. Lupus 2004;13:168–176.
  • Statkute L, et al. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hemato-poietic stem cell transplantation. Blood 2005;106:2700–2709.
  • Marmont AM, et al. Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34 ) cell transplantation. Lupus 2006;15:44–46.
  • Lu Q, et al. Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus. Bone Marrow Transplant 2006;37:979–981.
  • Snowden JA, Passweg J, Moore JJ, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. J Rheumatol 2004;31:482–488.
  • McColl G, et al. High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999;131:507–509.
  • Burt RK, Omaya Y, Verda L, et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004;50:2466–2470.
  • Van Oosterhout M, et al. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: Poor response associated with persist-ence of host autoantibodies and synovial abnormalities. Ann Rheum Dis 2005;64:1783–1785.
  • De Kleer IM, et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004;63:1318–1326.
  • Matteson EL, et al. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis classification cri-teria cohort. Am J Med 1996;101:129–134.
  • Keogh KA, et al. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody associated vasculitis. Arthritis Rheum 2005;52:262–268.
  • Kotter I, et al. Autologous stem cell transplantation of treatment-resistant systemic vasculitis-a single center experi-ence and review of the literature. Clin Nephrol 2005; 64:485–489.
  • Maurer B, et al. Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involve-ment: Analysis after 5 years of follow up. Ann Rheum Dis 2006;65:127–129.
  • Rossi G, et al. Autologous hematopoietic stem cell transplan-tation for severe/refractory intestinal Behcet disease. Blood 2004;103:748–750.
  • Kunitomi A, et al. Bone marrow transplantation with a reduced-intensity conditioning regimen in a patient with Wegener granulomatosis and therapy-related leukemia. Int J Hematol 2006;83:262–265.
  • Marmont AM, et al. Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement. Bone Marrow Transplant 2006;37:1061–1063.
  • Daikeler T, et al. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis-a retrospective analysis of patients recorded to the European Bone Marrow Transplantation (EBMT) and European League Against Rheumatism (EULAR) databases and a review of the literature. Ann Rheum Dis 2007;66:202–207.
  • Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221–1231.
  • Burt RK, et al. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neural 2005;62:860–864.
  • Saccardi R. Autologous stem cell transplantation for progress-ive multiple sclerosis: Update of the European Group for Blood and Marrow TransplantationAutoimmune Diseases Working Party Database. Mult Scler 2006;12:814–823.
  • Samijn JP, et al. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry 2006;77:46–50.
  • Burt RK, et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: Failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003;102:2373–2378.
  • Nash RA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003;102:2364–2372.
  • Capella E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL,Italian GITMO-Neuro Intergroup on ASCT for Multiple Sclerosis. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Neural Sci 2005;26(Suppl 4):S200–S203.
  • Vermeulen M, Van Oers MH. Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neural Neurosurg Psychiatry 2002;72:127–128.
  • Kamat AV, et al. Autologous peripheral blood progenitor cell transplantation in refractory chronic inflammatory demyeli-nating polyradiculpathy. Bone Marrow Transplant 2005;37(Suppl):S132.
  • Oyama Y, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005;128:552–563.
  • Kreisel W, et al. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 2003;32:337–340.
  • Sorour Y, et al. High dose immunoablative therapy and autologous stem cell transplantation in severe resistant Crohn's disesase. Bone Marrow Transplant 2006;37(Suppl):S341.
  • Al-toma A, et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells. Blood 2006;, in press/on line publication.
  • Huhn RD, et al. High-dose cyclophosphamide with auto-logous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic auto-immune thrombocytopenia. Blood 2003;101:71–77.
  • Passweg JR, et al. Haematopoeitic stem cell transplantation for refractory auto immune cytopenia. Br J Haematol 2004;125:749–755.
  • Urban C, et al. Successful unrelated cord blood transplan-tation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell trans-plantation. Eur J Haematol 2006;76:526–530.
  • Marmont AM, et al. Refractory Evans' syndrome treated with allogeneic SCT followed by DLL Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003;31:399–402.
  • Marmont AM, et al. Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs. Biol Blood Marrow Transplant 2006; 12(9):987–989.
  • Voltarelli J, et al. Autologous haemopoietic stem cell transplantation for type I diabetes. Bone Marrow Transplant 2006;37 (Suppl):S16.
  • Bingham S, et al. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum 2002;46(3):837–839.
  • Muraro PA, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005;201(5):805–816.
  • Van Laar JM, Farge D, Tyndall A. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: Hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 2005;64(10):1515.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.